Algert Global LLC Exelixis, Inc. Transaction History

Algert Global LLC

$4.25 Billion
Q4 2024

A detailed history of Algert Global LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Algert Global LLC holds 179,486 shares of EXEL stock, worth $6.92 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

179,486

Previous 276,040 34.98%

Holding current value

$6.92 Million

Previous $7.16 Million 16.56%

% of portfolio

0.14%

Previous 0.19%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$25.39 - $36.46 $2.45 Million - $3.52 Million	-96,554 Reduced 34.98%	179,486 $5.98 Million
Q3 2024 Nov 12, 2024	SELL	$21.96 - $27.6 $6,851 - $8,611	-312 Reduced 0.11%	276,040 $7.16 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $397,830 - $464,135	19,559 Added 7.62%	276,352 $6.21 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $454,300 - $569,468	-23,600 Reduced 8.42%	256,793 $6.16 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $638,030 - $762,017	33,510 Added 13.57%	280,393 $6.13 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $1.81 Million - $2.04 Million	99,660 Added 67.69%	246,883 $4.72 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $199,479 - $237,539	12,238 Added 9.07%	147,223 $2.86 Million
Q4 2022 Feb 13, 2023	BUY	$14.96 - $17.39 $271,673 - $315,802	18,160 Added 15.54%	134,985 $2.17 Million
Q3 2022 Nov 15, 2022	BUY	$15.68 - $22.27 $273,741 - $388,789	17,458 Added 17.57%	116,825 $1.83 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $10,638 - $14,127	-610 Reduced 0.61%	99,367 $2.07 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $379,513 - $505,200	22,285 Added 28.68%	99,977 $2.27 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $364,161 - $503,021	-22,990 Reduced 22.83%	77,692 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $1.64 Million - $2.13 Million	100,682 New	100,682 $2.13 Million

Others Institutions Holding EXEL

# of Institutions

566

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Exelixis, Inc. Transaction History